ArticleFrontiers in neurology2024

Safety considerations in the treatment with anti-CGRP(R) monoclonal antibodies in patients with migraine.

Britt W H Van Der Arend et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.